|
It was reported that a multifocal toric intraocular lens (iol) was explanted from the patient's right eye due to suboptimal vision.Prior to explantation, the patient experienced difficulty with both distance and near vision and was unable to drive at night due to halos.The patient experienced a loss of two or more lines of best spectacle-corrected visual acuity (bscva), decreasing from a preoperative bscva of 20/25 to a postoperative bscva of 20/40.Preoperative refraction was reported as -2.75 +1.25 x 180, and postoperative refraction was -1.50 sphere, with an intended target refraction of plano.The patient was not reported to be over-corrected or under-corrected.A history of previous lasik surgery was reported.The lens was replaced with a non-johnson & johnson lens of lower diopter power (17.0d).No patient injury, such as a capsule tear, was reported.No medical intervention, including vitrectomy, sutures, incision enlargement, or medications outside the standard of care, was required, and no planned surgical interventions were reported.The procedure was completed successfully, and the patient was reported to be doing well.The customer indicated that the device did not cause or contribute to the reported event.The product was not returned for evaluation because it was discarded.No further information was provided.
|
|
Section a5: ethnicity: unknown, information was requested but not provided.Section h3: the device was not returned for evaluation as it was discarded; therefore, a failure analysis of the complaint device cannot be completed.A review of records including device history and complaint trending will be performed.Upon completion of this review, if there is any further relevant information, a supplemental medwatch will be filed.Section h6: health effect - clinical code: 2138 - unexpected postop refraction; 2138 - vision loss (nos).Attempts were made to obtain additional information regarding the event; however, the information was not provided.All pertinent information available to johnson & johnson surgical vision, inc.Has been submitted.
|